Cancer survivors aged 40 years or elder are associated with high risk of chronic kidney disease: the 2010-2012 Korean National Health and Nutrition Examination Survey by 媛뺥씗�깮 et al.
Asian Pacific Journal of Cancer Prevention, Vol 16, 2015 1355
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.4.1355
Elevated Risk of Chronic Kidney Disease in Korean Cancer Survivors 
Asian Pac J Cancer Prev, 16 (4), 1355-1360
Introduction
Cancer survivors are defined as “individuals who have 
experienced any kind of malignancies and are still alive” 
(Denlinger et al., 2014). The number of cancer survivors 
is increasing globally, with approximately 13.7 million in 
the US (Centers for Disease, et al., 2011) and one million 
in Korea. In Korea, there were a reported 426,824 cancer 
survivors over 65 years old in 2012. This might be due to 
a range of factors, including earlier detection of cancer, 
improved cancer treatments, and increased national public 
health concern (Denlinger et al., 2014). Recently, higher 
rates of comorbidities in cancer survivors than in the 
general population have been reported. The presence of 
comorbidities, such as cardiovascular, cerebrovascular, 
and other chronic diseases including hypertension and 
diabetes, could threaten cancer survivors’ life expectancy 
and quality of life (Ogle et al., 2000). As a result of these 
increased risks, it is necessary for public health authorities 
to pay special attention to the care of cancer survivors.
Chronic kidney disease is a global epidemic disease. 
The global trend towards an aged population is related 
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Abstract
 Background: The number of cancer survivors is increasing globally and recently, higher rates of comorbidities 
in cancer survivors have been reported. However, no studies have investigated whether cancer survivors have 
a higher risk of chronic kidney disease (CKD). Accordingly, our study evaluated the association between 
cancer survivors and the risk of CKD using the 2010-2012 Korean National Health and Nutrition Examination 
Survey.  Materials and Methods: A total of 11,407 participants aged 40 years and over were categorized into 
two groups according to cancer experience. Multiple variables were compared and the odds ratios (ORs) for 
CKD prevalence were calculated using a weighted logistic regression analysis between the two groups. Results: 
Cancer survivors were older than were those in the non-cancer group, on average, the percentages of glomerular 
filtration rate(GFR) lower than 60mL/min/1.73m2, proteinuria, and CKD were significantly higher in cancer 
survivors when compared to controls. Weighted logistic regression analyses demonstrated that cancer survivors 
had a higher risk for CKD after adjusting for multiple variables (OR (95% confidence interval), 2.88 (1.48-
5.59)). Conclusions: Our study demonstrated a possible association between CKD and cancer survival in Korean 
adults. Identifying and correcting risk factors for cancer survivors would positively affect prevention of CKD 
and result in a better cancer prognosis.  
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to increasing CKD prevalence. The burden of CKD 
on public health is increasing in severity (Jha et al., 
2013). Modifiable lifestyle behaviors, such as smoking 
cigarettes, drinking alcohol, and physical inactivity, are 
well-known causes of CKD, in addition to aging. CKD 
shares these risk factors with cancers and cardiovascular 
diseases, which are the main causes of death among 
cancer survivors (Foundation, 2002; Levey et al., 2005; 
White et al., 2009; Stump, 2011). Several studies have 
reported that patients with renal impairment are more 
susceptible to developing cancer (Maisonneuve et al., 
1999; Cengiz et al., 2002). However, no studies have 
investigated whether cancer survivors are at a higher risk 
of developing CKD. Accordingly, we aimed to evaluate 
the association between cancer survival and risk of CKD 
using the 2010-2012 Korean National Health and Nutrition 
Examination Survey.
Materials and Methods
Study population
The Korean National Health and Nutrition Examination 
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Survey is a nationwide survey representing the general 
Korean population that is conducted by the Korean 
Ministry of Health and Welfare. It includes comprehensive 
information on health status, health behavior, and socio-
demographics. The sampling units were households 
selected using a stratified, multistage, probability-sampling 
design according to geographic area, sex, and age group 
based on household registries. Participants were asked to 
complete four parts of a questionnaire: a health interview 
survey, health behavior survey, health examination survey, 
and nutrition survey. The health interview survey was 
conducted through face-to-face interviews at participants’ 
homes by trained interviewers. Citizens had the right to 
refuse participation according to the National Health 
Enhancement Act. Participants who agreed to participate 
provided written informed consent. The Korea Centers 
for Disease Control and Prevention obtained participants’ 
agreement to use blood samples taken during the health 
interview survey for further research.
This study was based on data from 19,394 adults in 
192 national districts obtained from the Korean National 
Health and Nutrition Examination Survey V (2010-2012). 
We excluded participants younger than 40 years (n=4.474), 
those who had incomplete laboratory data (N=3.231), and 
those who did not have information regarding cancer 
diagnosis (N=280). After these exclusions, 11,409 were 
included in the final analysis. The Institutional Review 
Board of the Korea Centers for Disease Control and 
Prevention approved this study.
Measurement of anthropometry and laboratory data
Trained medical staff performed the physical 
examinations by following standardized procedures. 
Body weight and height were measured to the nearest 0.1 
kg and 0.1 cm, respectively, with subjects wearing light 
indoor clothing without shoes. Body mass index (BMI) 
was calculated as the ratio of weight in kilograms to height 
in squared meters. Blood pressure was measured twice 
on the right arm at 5-minute intervals using a standard 
mercury sphygmomanometer (Baumanometer; Baum, 
Copiague, NY, USA) and recorded as an averaged value. 
After overnight fasting, blood samples were obtained from 
participants’ antecubital veins. Levels of fasting plasma 
glucose, total cholesterol, and creatinine were measured 
enzymatically using a Hitachi Automatic Analyzer 7600 
(Hitachi, Japan). Dipstick urinalyses were conducted with 
an Urisys 2400 (Roche, Germany).
Definition of cancer survivor, chronic kidney disease, and 
health-related lifestyle factors
Participants who answered “Yes” to “Have you ever 
been diagnosed with any kind of cancer or malignancy 
in your life?” were classified as cancer survivors. Those 
who answered “No” were the control group.
An estimated GFR was calculated using the abbreviated 
equation from the Modification of Diet in Renal 
Disease (MDRD) study: estimated GFR (mL/min/1.73 
m2)=186.3×(serum creatinine-1.154)×(age-0.203)×0.742 (if 
female). CKD was defined based on either renal tissue 
damage or reduced renal function. CKD was defined as 
estimated GFR <60 mL/min/1.73 m2 or proteinuria 1+ 
or greater. Proteinuria was tested using dipstick methods 
with freshly voided urine samples.
Information on health-related lifestyles was obtained 
from data gathered from the self-report questionnaire 
during the interview portion of each survey period. 
Individuals who engaged in ≥20 min of vigorous-
intensity physical activity at least three days a week or 
≥30 min of light- to moderate-intensity physical activity 
at least five days a week were categorized as the regular 
exercise group using the short form of the International 
Physical Activity Questionnaire (IPAQ). To identify 
high-risk drinkers, we used the Alcohol Use Disorders 
Identification Test (AUDIT), which consists of three 
domains: hazardous alcohol use, dependence symptoms, 
and harmful alcohol use (Thomas et al., 2001). The cut-
off points of the AUDIT score were categorized into three 
groups: low-risk drinkers, 0-7; intermediate-risk drinkers, 
8-14; and high-risk drinkers, ≥15 points. Individuals 
who smoked cigarettes during the relevant survey period 
were categorized as current smokers. Daily calorie intake 
was monitored by a 24-h food recall and analyzed using 
CAN-Pro 3.0 software (Korean Nutrition Society, Seoul, 
Korea). The prevalence of diabetes mellitus was calculated 
using the number of people who answered “yes” to 
either of the following questions: “have you ever been 
diagnosed with diabetes mellitus?” or “are you currently 
taking any medication for diabetes mellitus?” Similarly, 
the prevalence of hypertension was calculated using the 
number of people who answered “yes” to either of the 
following questions: “have you ever been diagnosed 
with hypertension?” or “are you currently taking any 
medication for hypertension?” 
Statistical analysis
Data taken from the Korea National Statistical Office 
was used to define the standard population. In order to 
represent the entire population of Korean adults without 
biased estimates, sampling weights were used to account 
for the complex sampling. All data from continuous 
variables are presented as means and standard errors 
(SEs). Data from categorical variables are presented as 
percentages. Student t-tests and chi-squared tests were 
used to compare mean values for continuous variables 
and percentages for categorical variables, respectively, 
by cancer survival status. The odds ratios (ORs) and 
corresponding 95% confidence intervals (95%CI) for 
risk of CKD were calculated using weighted multivariate 
logistic regression analyses. All analyses were conducted 
using SAS statistical software, version 9.2 (SAS Institute 
Inc, Cary, NC). All statistical tests were two-tailed and 
statistical significance was determined as p<0.05.
Results 
The characteristics of the study participants are 
summarized in Table 1. The mean age was 55.8 years 
old and the rate of cancer survivors was 5.3%. The mean 
value of GFR and creatinine levels were 90.5 mL/min/1.73 
m2 and 0.85 mg/dL, respectively. Cancer survivors were 
significantly older than were those in the non-cancer 
group, and a mean of 18.5 years had passed since cancer 
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survivors were initially diagnosed. Mean BMI, diastolic 
blood pressure, daily calorie intake, and monthly 
household income were significantly lower in cancer 
survivors than in the non-cancer group. The mean GFR 
was lower in cancer survivors (87.5 in cancer survivors 
vs 90.7 mL/min/1.73 m2 in the non-cancer group), while 
mean levels of creatinine were not significantly different 
between the two groups. The percentages of regular 
exercisers, high-risk drinkers, and current smokers were 
lower in cancer survivors. The prevalence of diabetes 
mellitus was higher in cancer survivors; however, the 
prevalence of hypertension did not significantly differ 
between the two groups. 
Figure 1 shows GFR, the prevalence of proteinuria 
and CKD by cancer experience. There was a significant 
difference (p<0.001) between the percentage of 
participants with GFR lower than 60mL/min/1.73 m2 
between cancer survivors (6.2%) and the non-cancer 
group (3.0%). Although the prevalence of proteinuria 
was not significantly different between groups (2.2% 
in cancer survivors and 1.4% in the non-cancer group; 
p=0.280), prevalence of CKD was significantly different 
(7.4% in cancer survivors compared to 4% in the 
non-cancer group; p=0.001). We performed weighted 
logistic regression analyses to examine whether cancer 
survivors demonstrated a higher risk for CKD (Table 
2). In comparison with the non-cancer group, age and 
sex-adjusted ORs (95%CIs) of cancer survivors for CKD 
were 1.48 (0.98-2.23) in Model 1. After adjusting for 
age, sex, systolic blood pressure, BMI, fasting plasma 
glucose, total cholesterol, daily calorie intake, and monthly 
household income, ORs (95%CIs) of cancer survivors 
for CKD were 1.51 (0.98-2.33) in Model 2. After fully 
adjusting for lifestyle factors (exercise, smoking, and 
alcohol consumption) and the potential confounding 
factors in Model 2, the OR (95%CI) were 2.88 (1.48-
5.59) in Model 3.
Table 1. Basic Characteristics of the Study Subjects
 Total Non-cancer Cancer Survivor p-valuea
Unweighted N (Female, %) 11.409 (52.2) 10727 (51.6) 682 (63.8) 
Age (years) 55.8±0.2 55.6±0.2  59.8±0.6 <0.001
Time since cancer diagnosis (years) NA NA 18.5±1.1 NA
Body mass index (kg/m²) 24.0±0.0 24.1±0.0 23.6±0.2 0.006
Systolic blood pressure (mmHg) 123.1±0.3 123.1±0.3 123.2±0.8 0.861
Diastolic blood pressure (mmHg) 78.1±0.2 78.1±0.2 76.5±0.5 0.001
Fasting plasma glucose (mg/dL) 101.0±0.3 100.9±0.3 101.7±1.1 0.503
Total cholesterol (mg/dL) 193.9±0.5 194.0±0.5 192.2±1.8 0.326
Creatinine (mg/dL) 0.85±0.00 0.85±0.00 0.84±0.01 0.504
GFR (mL/min/1.73m2) 90.5±0.3 90.7±0.3 87.5±0.8 <0.001
Calorie intake (Kcal/day) 1986.0±12.6 1998±13 1765±36 <0.001
Household income (Korean Won/month) 4291±159 4338±167 3434±358 0.023
Regular exerciser (%)b 45 45.4 38.8 0.006
High-risk drinker (%)b 16.1 16.3 10.2 0.018
Current smoker (%)b 25.8 26.7 9.4 <0.001
Prevalence of diabetes (%)b 8.6 10 12.7 <0.001
Prevalence of hypertension (%)b 50.9 54 45.9 0.483
*All data except regular exerciser, high-risk drinker, current smoker, prevalence of diabetes and prevalence of hypertension are represented as 
mean±SE; ap-values are determined by student t-tests between non-cancer and cancer survivor groups; bRegular exerciser, high-risk drinker, current 
smoker, prevalence of diabetes and prevalence of hypertension are represented as percentage and the p-values are determined by chi-square tests.
1 USD=1000 Korean Won; Regular exerciser: A person who incorporates ≥20 min of vigorous-intensity physical activity for ≥3 days a week, or 
light-/moderate-intensity physical activity ≥5 days a week High-risk drinker: AUDIT score ≥15 Abbreviations: GFR, glomerular filtration rate
Table 2. Odds Ratio for Chronic Kidney Disease 
According to Cancer Experiences
All OR (95%CI)
Model 1 1.48 (0.98-2.23)
Model 2 1.51 (0.98-2.33)
Model 3 2.88 (1.48-5.59)
*Model 1: adjusted for age and sex; Model 2: adjusted for age, sex, 
systolic blood pressure, body mass index, fasting plasma glucose, total 
cholesterol, daily calorie intake, and monthly house income; Model 3: 
adjusted for age, sex, systolic blood pressure, body mass index, fasting 
plasma glucose, total cholesterol, daily calorie intake, monthly house 
income, exercise status (Regular exerciser: ≥20 min of vigorous-intensity 
physical activity for ≥3 days a week, or light-/moderate-intensity physical 
activity ≥5 days a week), smoking status (never smoker, former smoker, 
current smoker), and drinking status (high-risk drinking: AUDIT score 
≥15)
Figure 1. The Percentage of Glomerular Filtration 
Rate Lesser than 60mL/min/1.73M2 and Proteinuria 
and the Prevalence of Chronic Kidney Disease among 
Cancer Survivors and Control Group
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Discussion
In the present study, we found that cancer survivors 
had a higher risk for CKD after adjusting for possible 
confounding factors such as age, sex, BMI, blood pressure, 
and lifestyle (cigarette smoking, alcohol drinking, and 
exercise status) in this nationally representative sample. 
Several previous studies have reported the association 
between CKD and cancer. Many have provided evidence 
that end-stage renal disease (ESRD) patients have 
increased risk of developing cancer; this could be 
explained by immunosuppression linked to uremia 
and immunosuppressive therapy after transplantation 
(Maisonneuve et al., 1999; Cengiz et al., 2002; Vajdic 
et al., 2006). Early-stage CKD has also been associated 
with a higher risk of cancer incidence (Cengiz et al., 
2002; Jorgensen et al., 2008). However, no studies had 
investigated whether adult cancer survivors are more 
susceptible to CKD than adults without cancer experience.
 One hypothesis that may explain this association 
between cancer survival and higher risk of CKD is that 
cancer survivors appear to be more vulnerable to kidney 
dysfunction and damage because they are typically 
older and have more comorbid conditions and cancer-
related conditions, such as cachexia and hypercalcemia 
(Airy et al., 2013). In addition, most survivors have 
undergone at least one anti-cancer therapy (i.e., surgery, 
chemotherapy, and radiation treatment). Some treatments, 
including cisplatin, carboplatin, ifosfamide, radiotherapy, 
and nephrectomy, are considered nephrotoxic and can 
cause renal dysfunction, proteinuria, and hypertension 
(Yao et al., 2007; Dekkers et al., 2013). Dekkers et al. 
(2013) demonstrated in a retrospective cohort study that 
adult childhood cancer survivors who were treated with 
cisplatin, ifosfamide, or abdominal radiation therapy 
(RT) with nephrectomy are at greater risk for kidney 
injury. Cisplatin is accumulated and biotransformed into 
highly reactive thiols in the kidney, thereby leading to 
kidney injury (Yao et al., 2007). Platinum-containing 
agents also mediate cytotoxic effects through nuclear and 
mitochondrial DNA damage and directly induce apoptosis 
of renal epithelial cells (Siddik et al., 2005). Furthermore, 
several anticancer agents increase inflammation through 
the release of inflammatory cytokine and attraction of 
inflammatory cells, resulting in the pathogenesis of 
nephrotoxicity (Yao et al., 2007). Renal cell cancer 
survivors are usually treated with unilateral nephrectomy. 
Compensatory hypertrophy and hyperfiltration of the 
remaining kidney after unilateral nephrectomy can have 
long-term effects such as glomerulosclerosis, proteinuria, 
and elevated blood pressure (Dekkers et al., 2013). RT 
can directly damage the kidneys and cause glomerular, 
tubular, and endothelial microvascular dysfunction in a 
dose-dependent manner (Quarmby et al., 1999). Acute 
RT-induced kidney damage is usually subclinical, while 
chronic RT-induced injury is characterized by elevated 
blood pressure, serum creatinine levels, and renal 
failure. The aforementioned anticancer treatments can 
indirectly cause hypertension and atherosclerosis, which 
independently affect CKD development. In addition 
to direct and indirect effects of individual anticancer 
treatments, other nephrotoxic agents, which are necessary 
to the development of infectious diseases, could influence 
the observed higher prevalence of CKD among cancer 
survivors.
Another possible explanation is that the pathogenesis 
of CKD shares the risk factors for cancer development. 
Diabetes and hypertension are the most common causes 
of CKD (Foundation, 2002; Levey et al., 2005). Both 
are closely related to modifiable lifestyle factors, such 
as smoking, drinking, and a sedentary lifestyle (Xin et 
al., 2001; Levey et al., 2005; Willi et al., 2007; Stump, 
2011). Tobacco is known to lead to hypertension, diabetes, 
and atherosclerosis, as well as CKD (Athyros et al., 
2013). Furthermore, it can worsen proteinuria and CKD 
in diabetic and hypertensive patients. Smoking is also 
considered a risk factor for several types of carcinoma 
(Steele et al., 2012). High-risk drinking is associated with 
renal tubular dysfunction, hypertension, and diabetes, all 
of which deteriorate kidney function (Steele et al., 2012). 
In particular, heavy alcohol intake also increases risk for 
cancers of the digestive system, such as colorectal and 
liver cancers (Fedirko et al., 2011; Grewal et al., 2012). 
Previous studies reported that physical activity might play 
a protective role in the incidence and progression of CKD 
through the improvement of vascular endothelial function, 
insulin sensitivity, and control of blood pressure (Johansen, 
2007; Stump, 2011). In addition, regular physical exercise 
can decrease oxidative stress, inflammation, and obesity 
risk. Accordingly, systematic reviews and meta-analyses 
have demonstrated that physical activity is inversely 
associated with cancer risk, including prostate, breast, 
and colon cancers, despite some debate on these topics 
(Wolin et al., 2009; Liu et al., 2011; Wu et al., 2013). Taken 
together, the aforementioned lifestyles could underlie the 
association between CKD and cancer. Unhealthy lifestyle 
behaviors, such as smoking, drinking, and physical 
inactivity, are likely to increase risk for both cancer and 
renal impairment. For these reasons, cancer survivors 
might be more vulnerable to CKD before cancer diagnosis. 
Anticancer treatments might lead to suffering from CKD 
through the cumulative effects of unhealthy lifestyles.
Several studies have demonstrated that cancer 
survivors tended to change from unhealthy lifestyles 
to healthier patterns after cancer diagnosis, including 
smoking cessation, cutting down on alcohol consumption, 
increased physical activity, and changing diet patterns 
(Gritz et al., 1991; Hounshell et al., 2001; Maskarinec 
et al., 2001; Duffy et al., 2002; Demark-Wahnefried 
et al., 2005; Sprague et al., 2010). This present study 
is consistent with those previous studies, showing that 
cancer survivors pursue healthier behaviors, with a lower 
percentage of current smokers, heavy drinkers and a lower 
daily calorie intake compared with the non-cancer group. 
In addition, cancer survivors had lower BMI and blood 
pressure. When adjusting for these confounding factors 
in logistic regression analyses, there appeared to be an 
effect on the ORs for CKD, which became statistically 
significant.
This study has several limitations. First, this is a 
cross-sectional design, so we could not determine the 
causality of the relationships. Second, The Kidney Disease 
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Outcomes Quality Initiative guideline defines CKD as 
the presence of either renal dysfunction (GFR <60 mL/
min/1.73 m2) or renal damage (proteinuria or albuminuria) 
lasting for ≥3 months (Foundation, 2002). However, we 
defined CKD using a single measurement of the estimated 
GFR based on the Modification of Diet in Renal Disease 
equation, which is not influenced by characteristics of the 
Korean population. Further, we employed the enzymatic 
method, which might not accurately estimate actual 
GFR37, to measure creatinine (as opposed to the Jaffe 
method, which is generally recommended) and tested 
for proteinuria using a dipstick test. Third, reporting 
bias might have been present, because the data from 
cancer survivors were collected through self-report 
questionnaires. Fourth, there is no information on cancer 
type among cancer survivors, which makes it impossible 
to specify risk according to cancer type. Despite these 
limitations, to our knowledge, this is the first study to 
examine the features of the association between CKD and 
cancer survival using national data in Korea. Moreover, 
using a weighted method adjusting for multiple variables, 
the ability to generalize the outcome is a strength of our 
study. 
In conclusion, our study demonstrated that cancer 
survivors appear to be at greater risk for CKD among 
Korean adults using nationally representative data. 
Prospective studies are necessary to establish more 
reliable, strategic, and practical plans for the prevention 
of CKD in cancer survivors and to minimize the burden 
on public health in the future.
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